Genetic Variability of μ-Opioid Receptor in an Obstetric Population

Anesthesiology

Volumn 100, Issue 4, 2004, Pages 1030-1033

  Landau, Ruth ^a   Cahana, Alex ^a   Smiley, Richard M ^b   Antonarakis, Stylianos E ^a   Blouin, Jean Louis ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b Columbia Univ Coll of Phys/Surgs ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ENDORPHIN; DIAMORPHINE; DNA; ENKEPHALIN; FENTANYL; METHADONE; MORPHINE; MU OPIATE RECEPTOR; OPIATE;

ADULT; ALLELE; ARTICLE; BINDING AFFINITY; CAUCASIAN; CHRONIC PAIN; DRUG RECEPTOR BINDING; DRUG TARGETING; ETHNIC GROUP; FEMALE; GENE; GENE LOCUS; GENETIC POLYMORPHISM; GENOTYPE; HISPANIC; HUMAN; MATERNAL AGE; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; OBSTETRIC ANALGESIA; OPRM1 GENE; PAIN; PHARMACOGENETICS; POLYMERASE CHAIN REACTION; POLYMORPHIC LOCUS; POSTOPERATIVE PAIN; PREGNANCY; PRIORITY JOURNAL; RACE DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; ANALGESIA, OBSTETRICAL; FEMALE; HUMANS; PAIN THRESHOLD; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY; RECEPTORS, OPIOID, MU; VARIATION (GENETICS);

EID: 1642272097     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200404000-00042     Document Type: Article

References (29)

1. Gaveriaux-Ruff C, Kieffer BL: Opioid receptor genes inactivated in mice: The highlights. Neuropeptides 2002; 36:62-71
2. Kieffer BL, Gaveriaux-Ruff C: Exploring the opioid system by gene knockout. Prog Neurobiol 2002; 66:285-306
3. Mogil JS: The genetic mediation of individual differences in sensitivity to pain and its inhibition. Proc Natl Acad Sci U S A 1999; 96:7744-51
4. Pasternak GW: The pharmacology of mu analgesics: From patients to genes. Neuroscientist 2001; 7:220-31
5. Uhl GR, Sora I, Wang Z: The mu opiate receptor as a candidate gene for pain: polymorphisms, variations in expression, nociception, and opiate responses. Proc Natl Acad Sci U S A 1999; 96:7752-5
6. Grosch S, Niederberger E, Lotsch J, Skarke C, Geisslinger G: A rapid screening method for a single nucleotide polymorphism (SNP) in the human MOR gene. Br J Clin Pharmacol 2001; 52:711-4
7. LaForge KS, Shick V, Spangler R, Proudnikov D, Yuferov V, Lysov Y, Mirzabekov A, Kreek MJ: Detection of single nucleotide polymorphisms of the human mu opioid receptor gene by hybridization or single nucleotide extension on custom oligonucleotide gelpad microchips: Potential in studies of addiction. Am J Med Genet 2000; 96:604-15
8. Pan YX: Identification of alternatively spliced variants from opioid receptor genes. Methods Mol Med 2003; 84:65-75
9. Wang JB, Johnson PS, Persico AM, Hawkins AL, Griffin CA, Uhl GR: Human mu opiate receptor: cDNA and genomic clones, pharmacologic characterization and chromosomal assignment. FEBS Lett 1994; 338:217-22
10. Xin L, Wang ZJ: Bioinformatic analysis of the human μ opioid receptor (OPRM1) splice and polymorphic variants. AAPS PharmSci 2002; 4(4 article 23):1-13
11. Bond C, LaForge KS, Tian M, Melia D, Zhang S, Borg L, Gong J, Schluger J, Strong JA, Leal SM, Tischfield JA, Kreek MJ, Yu L: Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: Possible implications for opiate addiction. Proc Natl Acad Sci U S A 1998; 95:9608-13
12. Gelernter J, Kranzler H, Cubells J: Genetics of two mu opioid receptor gene (OPRM1) exon I polymorphisms: Population studies, and allele frequencies in alcohol- and drug-dependent subjects. Mol Psychiatry 1999; 4:476-83
13. Neve B, Froguel P, Corset L, Vaillant E, Vatin V, Boutin P: Rapid SNP allele frequency determination in genomic DNA pools by pyrosequencing. Biotechniques 2002; 32:1138-42
14. Wasson J, Skolnick G, Love-Gregory L, Permutt MA: Assessing allele frequencies of single nucleotide polymorphisms in DNA pools by pyrosequencing technology. Biotechniques 2002; 32:1144-6, 1148, 1150
15. Tan EC, Tan CH, Karupathivan U, Yap EP: Mu opioid receptor gene polymorphisms and heroin dependence in Asian populations. Neuroreport 2003; 14:569-72
16. Compton P, Geschwind DH, Alarcón M: Association between human μ-opioid receptor gene polymorphism, pain tolerance, and opioid addiction. Am J Med Genet 2003; 121B:76-82
17. Befort K, Filliol D, Decaillot FM, Gaveriaux-Ruff C, Hoehe MR, Kieffer BL: A single nucleotide polymorphic mutation in the human mu-opioid receptor severely impairs receptor signaling. J Biol Chem 2001; 276:3130-7
18. Lotsch J, Skarke C, Grosch S, Darimont J, Schmidt H, Geisslinger G: The polymorphism A118G of the human mu-opioid receptor gene decreases the pupil constrictory effect of morphine-6-glucuronide but not that of morphine. Pharmacogenetics 2002; 12:3-9
19. Lotsch J, Zimmermann M, Darimont J, Marx C, Dudziak R, Skarke C, Geisslinger G: Does the A118G polymorphism at the mu-opioid receptor gene protect against morphine-6-glucuronide toxicity? ANESTHESIOLOGY 2002; 97:814-9
20. Hernandez-Avila CA, Wand G, Luo X, Gelernter J, Kranzler HR: Association between the cortisol response to opioid blockade and the Asn40Asp polymorphism at the mu-opioid receptor locus (OPRM1). Am J Med Genet 2003; 118B:60-5
21. Wand GS, McCaul M, Yang X, Reynolds J, Gotjen D, Lee S, Ali A: The mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade. Neuropsychopharmacology 2002; 26:106-14
22. Hall FS, Sora I, Uhl GR: Ethanol consumption and reward are decreased in mu-opiate receptor knockout mice. Psychopharmacology (Berl) 2001; 154:43-9
23. Herz A: Endogenous opioid systems and alcohol addiction. Psychopharmacology (Berl) 1997; 129:99-111
24. Town T, Abdullah L, Crawford F, Schinka J, Ordorica PI, Francis E, Hughes P, Duara R, Mullan M: Association of a functional mu-opioid receptor allele (+118A) with alcohol dependency. Am J Med Genet 1999; 88:458-61
25. Bergen AW, Kokoszka J, Peterson R, Long JC, Virkkunen M, Linnoila M, Goldman D: Mu opioid receptor gene variants: Lack of association with alcohol dependence. Mol Psychiatry 1997; 2:490-4
26. Sander T, Gscheidel N, Wendel B, Samochowiec J, Smolka M, Rommelspacher H, Schmidt LG, Hoehe MR: Human mu-opioid receptor variation and alcohol dependence. Alcohol Clin Exp Res 1998; 22:2108-10
27. Franke P, Wang T, Nothen MM, Knapp M, Neidt H, Albrecht S, Jahnes E, Propping P, Maier W: Nonreplication of association between mu-opioid-receptor gene (OPRM1) A118G polymorphism and substance dependence. Am J Med Genet 2001; 105:114-9
28. Schinka JA, Town T, Abdullah L, Crawford FC, Ordorica PI, Francis E, Hughes P, Graves AB, Mortimer JA, Mullan M: A functional polymorphism within the mu-opioid receptor gene and risk for abuse of alcohol and other substances. Mol Psychiatry 2002; 7:224-8
29. Oslin DW, Berrettini W, Kranzler HR, Pettinati H, Gelernter J, Volpicelli JR, O'Brien CP: A Functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology 2003; 28:1546-52